Oliver Rusch

Title: Innovations by Oliver Rusch in Opioid Treatment

Introduction

Oliver Rusch is an accomplished inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of opioid-induced constipation. With a total of three patents to his name, Rusch's work focuses on innovative methods and compositions that enhance patient care.

Latest Patents

Rusch's latest patents include a method and composition for the treatment of opioid-induced constipation. This invention involves a solid oral pharmaceutical dosage form that comprises an opioid receptor antagonist. The formulation is designed to provide effective treatment with a specific dosage of naloxone hydrochloride, ensuring a rapid first-pass metabolism and a consistent level of the drug in the bloodstream. Another notable patent is for naloxone single agent and multilayer tablets, which are designed to release the active substance in a prolonged manner. This composition aims to provide effective treatment over an extended period, addressing the needs of patients suffering from opioid-induced constipation.

Career Highlights

Throughout his career, Oliver Rusch has worked with reputable companies such as Develco Pharma Schweiz AG and Algobate AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical treatments.

Collaborations

Rusch has collaborated with notable professionals in the field, including Hélène Rey and Olaf Mundszinger. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.

Conclusion

Oliver Rusch's contributions to the pharmaceutical industry, particularly in the treatment of opioid-induced constipation, demonstrate his commitment to innovation and patient care. His patents reflect a deep understanding of pharmacology and a dedication to improving therapeutic options for patients.